Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

NCT02494713 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped slow enrollment; resource re-allocation

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Doxorubicin
DRUG: Ketoconazole
DRUG: Docetaxel
DRUG: Estramustine

Sponsor

The University of Texas Health Science Center, Houston